Commodore Capital’s Vaxcyte PCVX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-1,650,000
| Closed | -$62.3M | – | 37 |
|
|
2025
Q1 | $62.3M | Buy |
1,650,000
+25,000
| +2% | +$944K | 4.59% | 8 |
|
|
2024
Q4 | $133M | Buy |
1,625,000
+705,000
| +77% | +$57.7M | 9.75% | 2 |
|
|
2024
Q3 | $105M | Sell |
920,000
-385,000
| -30% | -$44M | 6.57% | 4 |
|
|
2024
Q2 | $98.5M | Buy |
1,305,000
+445,000
| +52% | +$33.6M | 6.73% | 4 |
|
|
2024
Q1 | $58.7M | Sell |
860,000
-240,000
| -22% | -$16.4M | 3.93% | 7 |
|
|
2023
Q4 | $69.1M | Hold |
1,100,000
| – | – | 6.04% | 6 |
|
|
2023
Q3 | $56.1M | Buy |
1,100,000
+85,000
| +8% | +$4.33M | 6.55% | 4 |
|
|
2023
Q2 | $50.7M | Buy |
1,015,000
+815,000
| +408% | +$40.7M | 5.7% | 8 |
|
|
2023
Q1 | $7.5M | Buy |
200,000
+26,519
| +15% | +$994K | 1.14% | 25 |
|
|
2022
Q4 | $8.32M | Buy |
+173,481
| New | +$8.32M | 1.25% | 27 |
|